| Myeloid-derived suppressor cells coming of age F Veglia, M Perego, D Gabrilovich Nature immunology 19 (2), 108-119, 2018 | 1604 | 2018 |
| Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity F Veglia, E Sanseviero, DI Gabrilovich Nature Reviews Immunology 21 (8), 485-498, 2021 | 1094 | 2021 |
| Fatty acid transport protein 2 reprograms neutrophils in cancer F Veglia, VA Tyurin, M Blasi, A De Leo, AV Kossenkov, L Donthireddy, ... Nature 569 (7754), 73-78, 2019 | 508 | 2019 |
| Dendritic cells in cancer: the role revisited F Veglia, DI Gabrilovich Current opinion in immunology 45, 43-51, 2017 | 453 | 2017 |
| Oxidized lipids block antigen cross-presentation by dendritic cells in cancer W Cao, R Ramakrishnan, VA Tuyrin, F Veglia, T Condamine, A Amoscato, ... The Journal of Immunology 192 (6), 2920-2931, 2014 | 255 | 2014 |
| Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer F Veglia, VA Tyurin, D Mohammadyani, M Blasi, EK Duperret, ... Nature communications 8 (1), 2122, 2017 | 239 | 2017 |
| Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice F Veglia, A Hashimoto, H Dweep, E Sanseviero, A De Leo, E Tcyganov, ... Journal of Experimental Medicine 218 (4), 2021 | 173 | 2021 |
| Myeloid cells in glioblastoma microenvironment A De Leo, A Ugolini, F Veglia Cells 10 (1), 18, 2020 | 111 | 2020 |
| Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs J Mastio, T Condamine, G Dominguez, AV Kossenkov, L Donthireddy, ... Journal of Experimental Medicine 216 (9), 2150-2169, 2019 | 101 | 2019 |
| Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer A Ugolini, VA Tyurin, YY Tyurina, EN Tcyganov, L Donthireddy, VE Kagan, ... JCI insight 5 (15), 2020 | 94 | 2020 |
| EGR1 is a gatekeeper of inflammatory enhancers in human macrophages M Trizzino, A Zucco, S Deliard, F Wang, E Barbieri, F Veglia, ... Science advances 7 (3), eaaz8836, 2021 | 90 | 2021 |
| Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway K Alicea-Torres, E Sanseviero, J Gui, J Chen, F Veglia, Q Yu, ... Nature communications 12 (1), 1717, 2021 | 68 | 2021 |
| The frequency of α4β7high memory CD4+ T cells correlates with susceptibility to rectal simian immunodeficiency virus infection E Martinelli, F Veglia, D Goode, N Guerra-Perez, M Aravantinou, J Arthos, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (4), 325-331, 2013 | 68 | 2013 |
| Polyclonal Treg cells enhance the activity of a mucosal adjuvant S Vendetti, TS Davidson, F Veglia, A Riccomi, DRM Negri, R Lindstedt, ... Immunology and cell biology 88 (7), 698-706, 2010 | 31 | 2010 |
| HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy IG Zizzari, F Veglia, F Taurino, H Rahimi, E Quaglino, F Belleudi, ... Journal of molecular medicine 89, 1231-1240, 2011 | 21 | 2011 |
| Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets D Bayik, CF Bartels, K Lovrenert, DC Watson, D Zhang, K Kay, A Lauko, ... bioRxiv, 2021.09. 27.461995, 2021 | 17 | 2021 |
| Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells F Veglia, E Sciaraffia, A Riccomi, D Pinto, DRM Negri, MT De Magistris, ... Infection and immunity 79 (3), 1300-1310, 2011 | 17 | 2011 |
| Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection N Guerra-Pérez, I Frank, F Veglia, M Aravantinou, D Goode, JL Blanchard, ... The Journal of Immunology 194 (5), 2415-2423, 2015 | 14 | 2015 |
| Rectal HSV-2 Infection may increase rectal SIV acquisition even in the context of SIVΔnef vaccination N Guerra-Pérez, M Aravantinou, F Veglia, D Goode, R Truong, N Derby, ... PloS one 11 (2), e0149491, 2016 | 13 | 2016 |
| Oxidized lipids contribute to the suppression function of myeloid derived suppressor cells in cancer F Veglia, V Tyurin, V Kagan, D Gabrilovich Cancer Research 75 (15_Supplement), 467-467, 2015 | 10 | 2015 |
Dmitry GabrilovichChief Scientist, Cancer Immunology, AstraZeneca在 astrazeneca.com 的电子邮件经过验证
